Anesa Mulabecirovic: Why Von Willebrand Disease Takes Years to Diagnose in Women
Anesa Mulabecirovic, Portfolio Manager at DNB Asset Management, shared a post on LinkedIn:
“The most common inherited bleeding disorder takes an average of sixteen years to diagnose in women.
Not because it is rare. It is not. The delay is about where the bleeding gets recorded.
A girl can bleed heavily from her first period, and the note that follows reads ‘heavy periods,’ not ‘possible clotting defect.’
She is routed to gynecology, not hematology. The symptom is counted. The disorder behind it is not.
Global registries identify von Willebrand disease in roughly 26 people per million.
Clinically significant disease runs closer to 1 in 1000.
Either way the treated population is a fraction of the real one, and the gap is a recording problem, not a biology one.
A market can only price what has a label.
The clinic meets the patient before the label exists, and that gap is larger than the numbers suggest.”
Stay updated with Hemostasis Today.
-
Jun 26, 2026, 16:32Kaitlin Lichty: A New Identity Reflecting a Shared Legacy of Bleeding Disorders
-
Jun 26, 2026, 16:07Toong Youttananukorn: The WFH Registry Driving Better Care and Advocacy
-
Jun 26, 2026, 15:51Heghine Khachatryan: Willebrand Disease – Similar Bleeding Phenotype, Distinct Pathophysiology
-
Jun 26, 2026, 15:37Von Willebrand Disease: New Diagnostic Approaches
-
Jun 26, 2026, 13:58Peter Bou Dib: How Factor IX Transformed Hemophilia B Treatment
-
Jun 26, 2026, 13:49Raghavendra Rao: The Surprising Link Between Chronic Venous Insufficiency and Falls
-
Jun 26, 2026, 13:40Caylynn Carls: Why Genetic Counseling Matters in Hemophilia Treatment
-
Jun 26, 2026, 13:25Ángel Cabrera: Clotting Disorders Behind Heavy Menstrual Bleeding
-
Jun 26, 2026, 13:02Turid Kjellevold: The Critical Role of Timely Hemostasis Testing